DruidElf44
8 minutes ago
Briefly checking in - interesting developments in the last weeks, not entirely unexpected given the lack of commercial progress. Let's hear what the new CEO has to say - let's have a clear, concrete, realistic near-term product roadmap, a candid status update on the PIC, and ideally some revenue gui
boi568
11 minutes ago
You should try to remember, as we discuss the ADL co-primary, that (1) the EMA is not requiring it and (2) the FDA is planning to drop it. So, at the heart of this discussion, it's not true that " he issue is with the [ADL] endpoint outcome." The remaining issue, to the extent one exists, is the tim